Matching slides 11,828
Current window 5,401-5,430
Pages 395
Rows per page 30
Slide function: Show Tractionclear collectionreset all

Slide function

5,401-5,430 of 11,828

filter-aware
33
The slide uses a split-view comparing historical annual data with recent half-year (1H) performance.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
37
The slide uses a stacked bar chart for revenue and a simple bar chart for EBITDA, followed by a summary of key performance drivers.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
38
The slide uses a 2x2 grid of metric cards to highlight performance.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
39
The slide uses a combination of a geographic map and a bar chart to illustrate business scale and future growth potential.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 1 hit
16
Slide displays a grid of logos representing various partners across four distinct distribution categories.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
17
The slide uses a two-column layout to contrast product development/contracts with regulatory compliance.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
20
Slide shows historical financial growth with FY 2023 estimates.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
04
The slide uses a Gantt-style chart to show clinical trial progress for multiple assets.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
12
The slide uses a simple additive framework to show how immune response and clinical activity lead to a strategic positioning as a 'backbone' therapy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
13
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
14
The chart is a classic 'spider plot' used in oncology to track individual patient tumor burden over time.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
15
Spider plot (swimmer plot variant) showing individual patient responses over time.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
17
Includes Kaplan-Meier survival curve and comparative efficacy tables.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
18
Includes a timeline of biopsy (Bx) and treatment, and paired dot plots showing pre/post treatment changes in CD68+ and CD3+ cell counts.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
19
Spider plot (swimmer plot variant) showing individual patient tumor response trajectories.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
23
Includes statistical significance markers (*, **, ***) and TGI (Tumor Growth Inhibition) percentages.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
13
The slide uses a process flow diagram to show the Phase 1b study arms.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
16
The slide uses a swimmer plot (left) and a waterfall plot (right) to visualize clinical response.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
17
The slide highlights clinical efficacy data from a Phase 1b trial (PROC).Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
20
The slide uses qualitative feedback from healthcare providers and KOLs to validate market demand.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
24
Includes footnotes comparing results to historical METEOR and CANTATA studies.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
31
Includes a footnote comparing results to a historical P3 study.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations 1 hit
12
The slide uses a line chart to demonstrate clinical efficacy over 12 weeks compared to baseline.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
21
The slide uses a vertical timeline/process flow to demonstrate the de-risking of the drug candidate from pre-clinical to Phase 2a.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
23
The slide highlights efficacy in cognitive endpoints for a specific patient population (DPNP).ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
24
CIAS likely refers to Cognitive Impairment Associated with Schizophrenia.ATAI | Investor Presentation Deck | 36 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
09
The slide serves as both a product showcase and a traction metric.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · Rising Success1 hit
22
The slide uses a generic stock image of a hand pointing at an upward trend line to symbolize growth.AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit
23
The chart uses a combination of a line graph for revenue and a vertical bar to mark a specific event (New Team Start Date).AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit